ABCG2 and cancer: Research indicates that this chemoresistance may be associated with enhanced drug efflux due to the upregulation of ABC transporters, such as MDR1, coupled with the epigenetic silencing of cancer inhibitor genes via DNA hypermethylation (Veschi et al., 2024).